[
    {
        "releaseTime": "Feb-24-23 12:03PM",
        "title": "Pfizer/BioNTech Seek Expanded Approval For Its Updated COVID-19 Shot As Primary Series Vaccination",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/pfizer-biontech-seek-expanded-approval-170348997.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-24-23 10:30AM",
        "title": "Pharma Stock Roundup: FDA Updates for SNY, PFE & Others, EU Nod to AZN Cancer Combo",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pharma-stock-roundup-fda-updates-153003030.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-24-23 09:43AM",
        "title": "UPDATE 2-Pfizer/BioNTech apply for full FDA approval of updated COVID vaccine",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/1-pfizer-biontech-apply-full-144331526.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-24-23 07:11AM",
        "title": "Q4 2022 OPKO Health Inc Earnings Call",
        "publisher": " Thomson Reuters StreetEvents",
        "webUrl": "https://finance.yahoo.com/news/q4-2022-opko-health-inc-121101786.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-24-23 01:00AM",
        "title": "Opko Health (OPK) Q4 2022 Earnings Call Transcript",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/5db40a05-6cee-3902-aeca-036479d929f3/opko-health-%28opk%29-q4-2022.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-23-23 12:18PM",
        "title": "Is Pfizer Stock A Buy Or A Sell After Pharma Giant Confirms Covid Downfall?",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/9a6f7dfd-febf-37fb-912a-e0504d778fbc/is-pfizer-stock-a-buy-or-a.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-23-23 10:43AM",
        "title": "GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With Gilead's: Study Shows",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/gsk-pfizer-backed-viiv-healthcares-154336744.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-23-23 09:15AM",
        "title": "Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/ab5f1ced-ef12-3d04-9618-69c7a1380a31/pharma-giant-pfizer-looks.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-22-23 03:51PM",
        "title": "12 Most Profitable Pharmaceutical Stocks Now",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-most-profitable-pharmaceutical-stocks-205133439.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-22-23 07:30AM",
        "title": "This Recession-Proof Company Has a Best-in-Class Dividend",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/8af7ae11-f0be-3a22-a19f-ce88cbbd62b8/this-recession-proof-company.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-22-23 06:45AM",
        "title": "Pfizers Elranatamab Receives FDA and EMA Filing Acceptance",
        "publisher": " Business Wire",
        "webUrl": "https://finance.yahoo.com/news/pfizer-elranatamab-receives-fda-ema-114500184.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-21-23 10:15AM",
        "title": "My 3 Biggest Stock Market Predictions for March",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/e017755d-f1bc-32ec-875e-53dd547a12d5/my-3-biggest-stock-market.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-21-23 10:13AM",
        "title": "The Argus High-Yield Model Portfolio",
        "publisher": " Argus Research",
        "webUrl": "https://finance.yahoo.com/m/823b315e-e5a4-3b1e-a173-daae0e219a49/the-argus-high-yield-model.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-21-23 06:45AM",
        "title": "U.S. FDA Accepts Biologics License Application for Pfizers Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review",
        "publisher": " Business Wire",
        "webUrl": "https://finance.yahoo.com/news/u-fda-accepts-biologics-license-114500315.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-21-23 05:35AM",
        "title": "3 Dividend Stocks to Buy on Sale",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/80e80e54-5bb5-3331-a131-10fade3f2470/3-dividend-stocks-to-buy-on.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-21-23 12:00AM",
        "title": "Pfizer pins hopes on record pipeline to recover from post-Covid hangover",
        "publisher": " Financial Times",
        "webUrl": "https://finance.yahoo.com/m/be285e09-987e-3491-a9bb-299034e0a728/pfizer-pins-hopes-on-record.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-20-23 09:00AM",
        "title": "Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pfizer-inc-pfe-attracting-investor-140002665.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-19-23 07:59AM",
        "title": "BioNTech sees UK trials on cancer vaccines starting this year - paper",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/biontech-sees-uk-trials-cancer-125915541.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-18-23 08:14AM",
        "title": "3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/28c0dbfd-4a62-3f1d-9e77-e649953cc03a/3-dirt-cheap-stocks-to-buy.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-17-23 04:05PM",
        "title": "Valneva Shares Topple As It Hits Ethics Roadblock With Pfizer In Lyme Disease Test",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/fa13fd0b-cc34-30f4-bcc8-dc6fe4add6a9/valneva-shares-topple-as-it.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-17-23 02:44PM",
        "title": "Pfizer Shuts Trial Sites for Lyme Disease Jab After Standards Breaches",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/4ba56294-dfb1-340a-89a0-8fa3abc53abe/pfizer-shuts-trial-sites-for.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-17-23 10:17AM",
        "title": "Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/pfizer-biontech-ready-london-court-151726268.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-17-23 09:13AM",
        "title": "Pfizer and Other Stocks That Havent Been Able to Snap Their Losing Streak",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/cafc417a-14ac-3718-8d96-29d07fd0f075/pfizer-and-other-stocks-that.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-17-23 08:33AM",
        "title": "Pharma Stock Roundup: FDA Nod to PFE Cibinqo for Adolescents, Updates From NVO, RHHBY",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pharma-stock-roundup-fda-nod-133301306.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-17-23 08:24AM",
        "title": "10 dividend stocks with yields as high as 6.5% from a value manager with a strong track record",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/a7b4f044-26d9-3b7f-a2c8-55dbe581ab03/10-dividend-stocks-with.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-17-23 07:47AM",
        "title": "Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/pfizer-valneva-discontinue-certain-trial-124756056.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-17-23 02:00AM",
        "title": "2022s Biggest Losers Are Among This Years Biggest Winners. Except for These Stocks.",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/cafc417a-14ac-3718-8d96-29d07fd0f075/2022%E2%80%99s-biggest-losers-are.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-17-23 01:13AM",
        "title": "Pfizer and Valneva discontinue some trials on vaccine against Lyme disease",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/pfizer-valneva-discontinue-trials-vaccine-061300201.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-16-23 06:34PM",
        "title": "Royalty Pharma plc (NASDAQ:RPRX) Q4 2022 Earnings Call Transcript",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/royalty-pharma-plc-nasdaq-rprx-233451312.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-16-23 01:10PM",
        "title": "Pfizer Releases Interim Update On PARP Inhibitor Combo Therapy For Prostate Cancer, Secures FDA Priority Review",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/pfizer-releases-interim-parp-inhibitor-181020525.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-16-23 11:05AM",
        "title": "Pfizer/BioNTech, Moderna gear up for 2024 London trial over COVID vaccine patents",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/pfizer-biontech-moderna-gear-2024-160524742.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-16-23 10:00AM",
        "title": "Pfizer Announces Positive TALZENNA® and XTANDI® Combination Data from Phase 3 TALAPRO-2 Study",
        "publisher": " Business Wire",
        "webUrl": "https://finance.yahoo.com/news/pfizer-announces-positive-talzenna-xtandi-150000357.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-16-23 06:45AM",
        "title": "Pfizer Announces The Lancet Neurology Has Published Phase 3 Data for Zavegepant for the Acute Treatment of Migraine in Adults",
        "publisher": " Business Wire",
        "webUrl": "https://finance.yahoo.com/news/pfizer-announces-lancet-neurology-published-114500177.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-15-23 05:24PM",
        "title": "Value Investor Joel Greenblatts Top 12 Dividend Picks",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/value-investor-joel-greenblatt-top-222445187.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-15-23 02:03PM",
        "title": "After IPO, Bausch + Lomb turns to an industry favorite to run the company",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/10670cca-f37d-311c-bd3b-7ca7cfecece4/after-ipo%2C-bausch-%2B-lomb.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-15-23 01:43PM",
        "title": "15 Most Profitable Dividend Stocks",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/15-most-profitable-dividend-stocks-184322757.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-14-23 12:31PM",
        "title": "Ray Dalio Stock Portfolio: Top 15 Stock Picks",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/ray-dalio-stock-portfolio-top-173110973.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-14-23 11:14AM",
        "title": "2 High-Yielding Dividend Stocks Trading Near 52-Week Lows",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/6f419d50-30f8-36df-afde-e65e6fbdb898/2-high-yielding-dividend.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-14-23 05:55AM",
        "title": "Is This the Telltale Sign to Sell Novavax Stock?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/5ad32e9c-ec69-348d-a479-6132fb2cdca5/is-this-the-telltale-sign-to.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-13-23 04:17PM",
        "title": "Collecting Pharmas Scraps Can Pay Off for This Biotech",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/d82b2971-322c-39fd-a47d-16ea101a08ec/collecting-pharma%E2%80%99s-scraps.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-13-23 08:35AM",
        "title": "Pfizer (PFE) Eczema Drug Cibinqo Gets FDA Nod for Adolescents",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pfizer-pfe-eczema-drug-cibinqo-133501838.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-13-23 08:15AM",
        "title": "Is This Dividend Stock a No-Brainer Buy?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/b493b132-543f-3141-b161-427b1def704c/is-this-dividend-stock-a.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-12-23 08:25PM",
        "title": "From Apple to VW, CEOs Gradually Returning to China After Its Reopening",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/445c414d-7597-31d8-bfe4-a1ec0fbfa7ca/from-apple-to-vw%2C-ceos.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-10-23 06:30PM",
        "title": "Gambling on Biotechsand Pfizer",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/988978e7-6772-3bed-9557-de7dc1a70cb0/gambling-on-biotechs%E2%80%94and.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-10-23 12:09PM",
        "title": "FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)",
        "publisher": " Business Wire",
        "webUrl": "https://finance.yahoo.com/news/fda-approves-pfizers-supplemental-drug-170900988.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-10-23 05:50AM",
        "title": "Is Novavax Stock a Buy With the New Normal for COVID?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/df052407-ad19-3eac-96fa-5a0cbd158f88/is-novavax-stock-a-buy-with.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-10-23 05:00AM",
        "title": "Zacks Market Edge Highlights: Pfizer, Exxon Mobil, Citigroup, Enterprise Products Partners and Intel",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/zacks-market-edge-highlights-pfizer-100010173.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-09-23 03:42PM",
        "title": "How to Build a Lottery Winning Stock Portfolio",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/build-lottery-winning-stock-portfolio-204208310.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-09-23 10:30AM",
        "title": "Hot to Build a Lottery Winning Stock Portfolio",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/hot-build-lottery-winning-stock-153003132.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-09-23 10:00AM",
        "title": "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
        "publisher": " Business Wire",
        "webUrl": "https://finance.yahoo.com/news/pfizer-invites-public-listen-webcast-150000869.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-09-23 10:00AM",
        "title": "2 Excellent Stocks to Buy in 2023 and Never Sell",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/c9efa38e-ad1d-3cea-87f4-46ebee3453f7/2-excellent-stocks-to-buy-in.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-09-23 05:52AM",
        "title": "3 Healthcare Stocks That Are Too Cheap to Ignore",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/c70aec30-1be1-378c-9a2b-216a12bafe21/3-healthcare-stocks-that-are.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-09-23 05:30AM",
        "title": "Pfizer, Novartis, Merck Executives Say They Are Hunting for Deals Again",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/91fa6a3a-0c12-3a46-82a9-db3419bf7082/pfizer%2C-novartis%2C-merck.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-08-23 10:05AM",
        "title": "A Look at Pharma ETFs Post Q4 Earnings",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/look-pharma-etfs-post-q4-150503275.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-08-23 08:43AM",
        "title": "Deciphera's (DCPH) Q4 Earnings Miss, Qinlock Drives Revenues",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/decipheras-dcph-q4-earnings-miss-134301250.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-07-23 09:00AM",
        "title": "Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pfizer-inc-pfe-trending-stock-140002452.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-07-23 08:15AM",
        "title": "Can Pfizer's Charts and Fundamentals Get on the Same Page?",
        "publisher": " TheStreet.com",
        "webUrl": "https://finance.yahoo.com/m/ab6bad1d-e0eb-3c7c-99fa-11b2fc1e49c3/can-pfizer%27s-charts-and.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-07-23 06:30AM",
        "title": "This Healthcare Giant Expects Revenue to Crash More Than 30% This Year",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/ffbb2c0c-b432-396c-b3d7-fe1121d8c0df/this-healthcare-giant-expects.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-06-23 07:34AM",
        "title": "Market Digest: AMGN, ASH, EPD, LAZ, MMM, MO, PFE, ROP, SBUX, SWK, APTV, AGNC",
        "publisher": " Argus Research",
        "webUrl": "https://finance.yahoo.com/m/2e60b201-8ef5-3b9f-a620-fe058f9ce19f/market-digest%3A-amgn%2C-ash%2C.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-06-23 07:34AM",
        "title": "Analyst Report: Pfizer Inc.",
        "publisher": " Argus Research",
        "webUrl": "https://finance.yahoo.com/m/c0042eee-b956-388a-90b8-1a91700dca2a/analyst-report%3A-pfizer-inc..html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-06-23 06:31AM",
        "title": "Fed Cuts Look Like a Dream, Not Reality. What It Means for Stocks.",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/2990b1b8-de25-3888-8abf-9541f2596e1d/fed-cuts-look-like-a-dream%2C.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-06-23 06:20AM",
        "title": "5 Stocks That Moved the Market in January",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/81aaa9b1-2aa4-3104-8b23-76d9c01dca4a/5-stocks-that-moved-the.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-06-23 06:05AM",
        "title": "Drug companies face COVID cliff in 2023 as sales set to plummet",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/drug-companies-face-covid-cliff-110539424.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-06-23 06:00AM",
        "title": "FOCUS-Drug companies face COVID cliff in 2023 as sales set to plummet",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/focus-drug-companies-face-covid-110000001.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-05-23 09:53AM",
        "title": "Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/abbda2a5-535c-3a60-bc49-c32974b2d8b3/pfizer-is-moving-beyond.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-05-23 08:46AM",
        "title": "12 Safe Stocks to Buy For Long-Term",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-safe-stocks-buy-long-134607791.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-04-23 08:00AM",
        "title": "Better Buy: Novavax or BioNTech Stock?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/c5ad36ef-a963-35f6-9657-2e16b8adbeed/better-buy%3A-novavax-or.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-03-23 01:19PM",
        "title": "10 Hot Healthcare Stocks To Buy Now",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/10-hot-healthcare-stocks-buy-181956435.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-03-23 11:34AM",
        "title": "UPDATE 1-China's CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/1-chinas-cansino-confident-mrna-163441867.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-03-23 10:52AM",
        "title": "China's CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/chinas-cansino-confident-mrna-covid-155255858.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-03-23 09:19AM",
        "title": "Is It Time to Buy the S&P 500's 3 Worst-Performing January Stocks?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/adf54ada-e41e-35e3-bbce-a1c4e076bba5/is-it-time-to-buy-the-s%26p.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-03-23 09:19AM",
        "title": "Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pharma-stock-roundup-mrk-lly-141902012.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-03-23 08:15AM",
        "title": "Regenerons Earnings Beat Forecasts, With No Sales of Covid-19 Treatment",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/cbfd38d1-937c-3a4f-9f14-33941078f2f1/regeneron%E2%80%99s-earnings-beat.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-02-23 06:29PM",
        "title": "COVID is 'pretty much out of the models' for pharma companies: Wells Fargo analyst",
        "publisher": " Yahoo Finance",
        "webUrl": "https://finance.yahoo.com/news/covid-is-pretty-much-out-of-the-models-for-pharma-companies-wells-fargo-analyst-232944434.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-02-23 02:59PM",
        "title": "Bristol-Myers (BMY) Q4 Earnings Top, Revlimid Generic Impact Sales",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/bristol-myers-bmy-q4-earnings-195907403.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-02-23 12:52PM",
        "title": "Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/32ef9696-a4fb-3587-82e0-9eefba6d9a75/here%27s-what%27s-next-for.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-02-23 12:07PM",
        "title": "Pharma earnings: COVID is highly uncertain for this year, analyst says",
        "publisher": " Yahoo Finance Video",
        "webUrl": "https://finance.yahoo.com/video/pharma-earnings-covid-highly-uncertain-170738758.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-02-23 09:25AM",
        "title": "UPDATE 1-BioNTech to invest $43 mln in German facility for mRNA vaccine building block",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/1-biontech-invest-43-mln-142516414.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-02-23 07:54AM",
        "title": "Got $1,000? 3 Cheap Stocks To Buy Right Now",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/9eb273b7-99e0-3f38-a5c3-f9805a0228e1/got-%241%2C000%3F-3-cheap-stocks-to.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-02-23 06:55AM",
        "title": "Pfizers former CFO says you should ask yourself these questions if you want to become a finance chief",
        "publisher": " Fortune",
        "webUrl": "https://finance.yahoo.com/news/pfizer-former-cfo-says-ask-115507228.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-02-23 06:45AM",
        "title": "BioNTech to invest $43 mln in German facility for mRNA vaccine building block",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/biontech-invest-43-mln-german-114500605.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-02-23 06:30AM",
        "title": "Merck fourth quarter tops expectations on strong COVID pill sales",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/merck-fourth-quarter-tops-expectations-113005158.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-02-23 05:50AM",
        "title": "Pfizer's Sales Could Sink 33% in 2023. Here's Why to Buy the Stock Anyway.",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/327c665e-f204-347e-abac-6a3d0d3fa215/pfizer%27s-sales-could-sink-33%25.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-01-23 05:47PM",
        "title": "Pfizer is expecting its covid windfall to end in 2023",
        "publisher": " Quartz",
        "webUrl": "https://finance.yahoo.com/news/pfizer-expecting-covid-windfall-end-224700472.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-01-23 03:30PM",
        "title": "Pfizer Inc. (NYSE:PFE) Q4 2022 Earnings Call Transcript",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/pfizer-inc-nyse-pfe-q4-203109513.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-01-23 09:20AM",
        "title": "Company News for Feb 1, 2023",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/company-news-feb-1-2023-142002525.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Feb-01-23 03:54AM",
        "title": "Pfizer (PFE) Reports Q4 Earnings: What Key Metrics Have to Say",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pfizer-pfe-reports-q4-earnings-085408120.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 07:00PM",
        "title": "Pfizer (PFE) Q4 2022 Earnings Call Transcript",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/207a897e-ea9f-3b55-a468-56f876f4d567/pfizer-%28pfe%29-q4-2022-earnings.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 06:10PM",
        "title": "Pfizer Can't Catch a Break, but Investors Can",
        "publisher": " GuruFocus.com",
        "webUrl": "https://finance.yahoo.com/news/pfizer-cant-catch-break-investors-231038546.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 06:08PM",
        "title": "Pfizer CEO: Covid Infections Will Rise. So Will Paxlovid and Vaccine Sales.",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/9144860b-8b67-3d2f-a253-1916d0b99bb3/pfizer-ceo%3A-covid-infections.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 04:48PM",
        "title": "The Worst-Performing S&P 500 Stocks in January",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/862179ba-255f-3044-a5bb-467c51739966/the-worst-performing-s%26p-500.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 04:25PM",
        "title": "These Stocks Moved the Most Today: GM, Spotify, Victorias Secret, and More",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/f603a6b3-c16a-35b7-88e1-18336dab5471/these-stocks-moved-the-most.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 04:11PM",
        "title": "Pfizer Loses $40 Billion of Value in Worst Month Since 2020",
        "publisher": " Bloomberg",
        "webUrl": "https://finance.yahoo.com/news/pfizer-loses-43-billion-value-160037753.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 04:03PM",
        "title": "The Expected Covid Cliff Is Here For Pfizer  Company Calls For Steep 2023 Declines",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/1d466ae2-4363-37ce-95f6-2dee4fd9e463/the-expected-covid-cliff-is.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 02:49PM",
        "title": "Pfizer Expects Drop in Revenue as Covid Vaccine Demand Wanes",
        "publisher": " The Wall Street Journal",
        "webUrl": "https://finance.yahoo.com/m/9dc44ba8-19d9-38ae-ae8d-ded6bd7ab056/pfizer-expects-drop-in.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 02:41PM",
        "title": "What Happens This Week Will Lead the Market for 2023",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/happens-week-lead-market-2023-194107339.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 02:26PM",
        "title": "With pandemic waning, Pfizer sees decline for its Covid products",
        "publisher": " American City Business Journals",
        "webUrl": "https://finance.yahoo.com/m/edf307a5-16c5-37b9-b008-7439c73c2464/with-pandemic-waning%2C-pfizer.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 01:52PM",
        "title": "Modernas stock is down as Pfizer lowers revenue estimates for its COVID vaccine for 2023",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/1bf0baa1-5117-3a98-8744-1a4f3b867654/moderna%E2%80%99s-stock-is-down-as.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 01:33PM",
        "title": "These Stocks Are Moving the Most Today: GM, Spotify, UPS, Caterpillar, and More",
        "publisher": " Barrons.com",
        "webUrl": "https://finance.yahoo.com/m/f603a6b3-c16a-35b7-88e1-18336dab5471/these-stocks-are-moving-the.html",
        "company": "PFE"
    },
    {
        "releaseTime": "Jan-31-23 01:16PM",
        "title": "Pfizers COVID revenues have dropped off along with attention to the pandemic",
        "publisher": " MarketWatch",
        "webUrl": "https://finance.yahoo.com/m/66b99d70-e272-3a5b-9fd5-f5d75ee62eeb/pfizer%E2%80%99s-covid-revenues-have.html",
        "company": "PFE"
    }
]